Additionally, Wang et al. (32) reported the involvement of Egr-1 in coronary microembolization (CME), a thrombotic and microinfarction complication that can arise in acute coronary syndrome patients during percutaneous coronary intervention (PCI) and result in no reflow. This evidence concerns the gene EGR1 and acute coronary syndrome.